Feshbach Bros. Scrutinized: Federal officials are investigating...
Feshbach Bros. Scrutinized: Federal officials are investigating whether a Palo Alto investment firm received confidential information from Food and Drug Administration employees as part of a probe into possible insider stock trading, according to a government source. A prime focus of the investigation is whether FDA officials leaked information to Feshbach Bros., although other companies also may come under scrutiny, the source said. Joseph Feshbach, a partner in the firm, denied wrongdoing. He said the company has had no contact with government investigators and was unaware of such a probe.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.